Showing results (21-30 of 60) with videos related to
Sort By:
Pageof 6
Leukemia & Lymphoma|February 26, 1999
Drug resistance in multiple myeloma: novel therapeutic targets within the malignant cloneL M Pilarski, M J Mant, A R BelchThe Journal of Clinical Investigation|June 1, 1985
Abnormal function of B lymphocytes from peripheral blood of multiple myeloma patients. Lack of correlation between the number of cells potentially able to secrete immunoglobulin M and serum immunoglobulin M levelsL M Pilarski, B A Ruether, M J MantClinical and Laboratory Haematology|January 1, 1987
Bone marrow granulocyte reserve in chronic benign idiopathic neutropeniaM J Mant, P A Gordon, J J AkabutuArchives of Internal Medicine|February 1, 1986
Lithium carbonate therapy in severe Felty's syndrome. Benefits, toxicity, and granulocyte functionM J Mant, J J Akabutu, F A HerbertScandinavian Journal of Haematology|October 1, 1975
Pseudothrombocytopenia due to platelet aggregation and degranulation in blood collected in EDTAM J Mant, J C Doery, J Gauldie, et al.Thyroid : Official Journal of the American Thyroid Association|January 1, 1994
Plasma cell lesions of the thyroid: report of a case of solitary plasmacytoma and a review of the literatureC S Kovacs, M J Mant, G K Nguyen, et al.The Journal of Clinical Investigation|October 1, 1984
Severe deficiency of B lymphocytes in peripheral blood from multiple myeloma patientsL M Pilarski, M J Mant, B A Ruether, et al.Critical Care Medicine|July 1, 1979
Severe thrombocytopenia probably due to acute folic acid deficiencyM J Mant, T Connolly, P A Gordon, et al.Blood|February 25, 1999
Overexpression of the receptor for hyaluronan-mediated motility (RHAMM) characterizes the malignant clone in multiple myeloma: identification of three distinct RHAMM variantsM Crainie, A R Belch, M J Mant, et al.International Immunology|January 1, 1989
Transition in CD45 isoform expression during differentiation of normal and abnormal B cellsG S Jensen, S Poppema, M J Mant, et al.Pageof 6